Voloridge Investment Management
FOLD

Voloridge Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Voloridge Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-561,133
Closed -$7.99M – 1102
2025
Q4 		$7.99M Sell
561,133
-125,211
-18% -$1.23M 0.03% 643
2025
Q3 		$5.41M Sell
686,344
-1,536,497
-69% -$10.9M 0.02% 721
2025
Q2 		$12.7M Buy
2,222,841
+1,748,040
+368% +$11.3M 0.05% 470
2025
Q1 		$3.87M Sell
474,801
-405,311
-46% -$3.75M 0.01% 842
2024
Q4 		$8.29M Sell
880,112
-397,497
-31% -$4.13M 0.03% 632
2024
Q3 		$13.6M Sell
1,277,609
-18,626
-1% -$203K 0.05% 482
2024
Q2 		$12.9M Sell
1,296,235
-16,935
-1% -$174K 0.05% 505
2024
Q1 		$15.5M Buy
1,313,170
+578,303
+79% +$7.4M 0.06% 387
2023
Q4 		$10.4M Buy
+734,867
New +$8.34M 0.04% 467
2022
Q3 		– Sell
-47,952
Closed -$515K – 1468
2022
Q2 		$515K Buy
47,952
+2,706
+6% +$22.3K ﹤0.01% 1296
2022
Q1 		$428K Sell
45,246
-222,600
-83% -$2.09M ﹤0.01% 1235
2021
Q4 		$3.09M Sell
267,846
-331,999
-55% -$3.7M 0.02% 907
2021
Q3 		$5.73M Sell
599,845
-338,887
-36% -$3.47M 0.04% 627
2021
Q2 		$9.05M Sell
938,732
-823,133
-47% -$8.03M 0.06% 440
2021
Q1 		$17.4M Buy
1,761,865
+1,596,072
+963% +$24.7M 0.13% 206
2020
Q4 		$3.83M Buy
165,793
+73,797
+80% +$1.51M 0.03% 517
2020
Q3 		$1.3M Sell
91,996
-2,479
-3% -$36.1K 0.01% 855
2020
Q2 		$1.43M Buy
94,475
+2,530
+3% +$30.8K 0.02% 725
2020
Q1 		$850K Buy
+91,945
New +$874K 0.02% 555
2017
Q4 		– Sell
-362,440
Closed -$5.47M – 524
2017
Q3 		$5.47M Buy
362,440
+61,297
+20% +$811K 0.12% 168
2017
Q2 		$3.03M Buy
+301,143
New +$2.42M 0.08% 232

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Voloridge Investment Management's FOLD Position: Q1 2026 in Review

Voloridge Investment Management sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 561,133 shares — an estimated $7.99M sold.

Voloridge Investment Management first reported a position in FOLD in Q2 2017 and held it in 21 quarters. The position peaked at $17.4M in Q1 2021. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Voloridge Investment Management reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 561,133 Amicus Therapeutics shares in Q1 2026, an estimated $7.99M.
  • Voloridge Investment Management first reported a position in Amicus Therapeutics in Q2 2017 and held it in 21 quarters.
  • Voloridge Investment Management's Amicus Therapeutics position peaked at $17.4M in Q1 2021.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.